Boditech Med Inc. (206640.KQ)

KRW 16600.0

(0.36%)

Gross Profit Summary of Boditech Med Inc.

Boditech Med Inc.'s latest annual gross profit in 2023 was 76.7 Billion KRW , up 13.8% from previous year.
Boditech Med Inc.'s latest quarterly gross profit in 2024 Q2 was 21.18 Billion KRW , up 10.76% from previous quarter.
Boditech Med Inc. reported a annual gross profit of 67.4 Billion KRW in annual gross profit 2022, down -29.82% from previous year.
Boditech Med Inc. reported a annual gross profit of 96.03 Billion KRW in annual gross profit 2021, up 0.36% from previous year.
Boditech Med Inc. reported a quarterly gross profit of 21.18 Billion KRW for 2024 Q2, up 10.76% from previous quarter.
Boditech Med Inc. reported a quarterly gross profit of 19.98 Billion KRW for 2023 Q2, up 20.9% from previous quarter.

Annual Gross Profit Chart of Boditech Med Inc. (2023 - 2015)

Historical Annual Gross Profit of Boditech Med Inc. (2023 - 2015)

Year	Gross Profit	Gross Profit Growth
2023	76.7 Billion KRW	13.8%
2022	67.4 Billion KRW	-29.82%
2021	96.03 Billion KRW	0.36%
2020	95.69 Billion KRW	145.82%
2019	38.93 Billion KRW	21.5%
2018	32.04 Billion KRW	11.68%
2017	28.69 Billion KRW	-14.31%
2016	33.48 Billion KRW	28.13%
2015	26.13 Billion KRW	0.0%

Year	Gross Profit	Gross Profit Growth
2024 Q1	19.12 Billion KRW	-6.13%
2024 Q2	21.18 Billion KRW	10.76%
2023 Q2	19.98 Billion KRW	20.9%
2023 FY	76.7 Billion KRW	13.8%
2023 Q3	19.81 Billion KRW	-0.82%
2023 Q1	16.52 Billion KRW	-5.12%
2023 Q4	20.37 Billion KRW	2.81%
2022 FY	67.4 Billion KRW	-29.82%
2022 Q1	21.45 Billion KRW	-0.02%
2022 Q2	13.26 Billion KRW	-38.16%
2022 Q3	15.26 Billion KRW	15.11%
2022 Q4	17.42 Billion KRW	14.09%
2021 FY	96.03 Billion KRW	0.36%
2021 Q3	25.88 Billion KRW	-1.48%
2021 Q1	22.42 Billion KRW	-41.97%
2021 Q2	26.27 Billion KRW	17.2%
2021 Q4	21.45 Billion KRW	-17.13%
2020 Q2	22.48 Billion KRW	147.07%
2020 FY	95.69 Billion KRW	145.82%
2020 Q4	38.63 Billion KRW	41.94%
2020 Q3	27.21 Billion KRW	21.06%
2020 Q1	9.09 Billion KRW	-15.76%
2019 Q4	10.8 Billion KRW	3.96%
2019 FY	38.93 Billion KRW	21.5%
2019 Q1	10.39 Billion KRW	10.32%
2019 Q2	9.23 Billion KRW	-11.23%
2019 Q3	10.39 Billion KRW	12.58%
2018 FY	32.04 Billion KRW	11.68%
2018 Q4	9.42 Billion KRW	6.49%
2018 Q2	7.79 Billion KRW	13.8%
2018 Q3	8.85 Billion KRW	13.6%
2018 Q1	6.84 Billion KRW	1.72%
2017 Q2	7.87 Billion KRW	-2.17%
2017 Q1	8.05 Billion KRW	2.61%
2017 FY	28.69 Billion KRW	-14.31%
2017 Q4	6.73 Billion KRW	1.41%
2017 Q3	6.63 Billion KRW	-15.73%
2016 Q2	10.04 Billion KRW	47.82%
2016 Q4	7.84 Billion KRW	-18.78%
2016 Q1	6.79 Billion KRW	-2.43%
2016 Q3	9.65 Billion KRW	-3.89%
2016 FY	33.48 Billion KRW	28.13%
2015 Q4	6.96 Billion KRW	-8.47%
2015 FY	26.13 Billion KRW	0.0%
2015 Q3	7.61 Billion KRW	9.56%
2015 Q1	5.04 Billion KRW	0.0%
2015 Q2	6.94 Billion KRW	37.7%

Peer Gross Profit Comparison of Boditech Med Inc.

Name	Gross Profit	Gross Profit Difference
HLB Pharmaceutical Co., Ltd	82.98 Billion KRW	7.568%
CMG Pharmaceutical Co., Ltd.	43.7 Billion KRW	-75.516%
Celltrion Pharm, Inc.	116.95 Billion KRW	34.418%
Huons Global Co., Ltd.	417.8 Billion KRW	81.641%
DongKook Pharmaceutical Co., Ltd.	405.04 Billion KRW	81.062%
Enzychem Lifesciences Corporation	3.29 Billion KRW	-2228.987%
Humedix Co., Ltd.	68.04 Billion KRW	-12.727%
EuBiologics Co., Ltd.	32.65 Billion KRW	-134.866%
FutureChem Co.,Ltd	758.27 Million KRW	-10015.776%
Huons Co., Ltd.	285.93 Billion KRW	73.174%
BNC Korea Co., Ltd.	31.97 Billion KRW	-139.868%
AptaBio Therapeutics Inc.	78.49 Million KRW	-97614.829%